John Mack suggests that less may be more in Gardasil’s case.
Related posts:
- Avandia: Patients partly to blame?
- More stupid Rozerem ads
- Celebrex: The new ad
- Exubera TV ads
- Blogs the new DTC?
- Are drug ads worth it during the Super Bowl?
- How to observe drug reps
KevinMD.com on Facebook
Comments on this entry are closed.